|4Jun 6, 9:48 AM ET

MCNALLY ROBERT T 4

4 · GeoVax Labs, Inc. · Filed Jun 6, 2025

Insider Transaction Report

Form 4
Period: 2025-06-05
MCNALLY ROBERT T
DirectorPresident & CEO
Transactions
  • Award

    Stock Option

    2025-06-05+10,00010,000 total
    Exercise: $2.48From: 2026-01-02Exp: 2035-01-02Common Stock (10,000 underlying)
Footnotes (1)
  • [F1]This stock option was granted on January 2, 2025, with the exercise price set based on the closing price of the underlying common stock as of that date. The stock option was granted contingent upon stockholder approval of the GeoVax Labs, Inc. 2025 Stock Incentive Plan. Such approval occurred on June 5, 2025, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4